330 related articles for article (PubMed ID: 18810647)
1. PPAR gamma ligands, rosiglitazone and pioglitazone, inhibit bFGF- and VEGF-mediated angiogenesis.
Aljada A; O'Connor L; Fu YY; Mousa SA
Angiogenesis; 2008; 11(4):361-7. PubMed ID: 18810647
[TBL] [Abstract][Full Text] [Related]
2. Rosiglitazone facilitates angiogenic progenitor cell differentiation toward endothelial lineage: a new paradigm in glitazone pleiotropy.
Wang CH; Ciliberti N; Li SH; Szmitko PE; Weisel RD; Fedak PW; Al-Omran M; Cherng WJ; Li RK; Stanford WL; Verma S
Circulation; 2004 Mar; 109(11):1392-400. PubMed ID: 14993120
[TBL] [Abstract][Full Text] [Related]
3. Tetraiodothyroacetic acid, a small molecule integrin ligand, blocks angiogenesis induced by vascular endothelial growth factor and basic fibroblast growth factor.
Mousa SA; Bergh JJ; Dier E; Rebbaa A; O'Connor LJ; Yalcin M; Aljada A; Dyskin E; Davis FB; Lin HY; Davis PJ
Angiogenesis; 2008; 11(2):183-90. PubMed ID: 18080776
[TBL] [Abstract][Full Text] [Related]
4. Selective activation of peroxisome proliferator-activated receptor (PPAR)alpha and PPAR gamma induces neoangiogenesis through a vascular endothelial growth factor-dependent mechanism.
Biscetti F; Gaetani E; Flex A; Aprahamian T; Hopkins T; Straface G; Pecorini G; Stigliano E; Smith RC; Angelini F; Castellot JJ; Pola R
Diabetes; 2008 May; 57(5):1394-404. PubMed ID: 18268046
[TBL] [Abstract][Full Text] [Related]
5. Nerve growth factor (NGF) promotes angiogenesis in the quail chorioallantoic membrane.
Lazarovici P; Gazit A; Staniszewska I; Marcinkiewicz C; Lelkes PI
Endothelium; 2006; 13(1):51-9. PubMed ID: 16885067
[TBL] [Abstract][Full Text] [Related]
6. Anti-inflammatory effect of antidiabetic thiazolidinediones prevents bone resorption rather than cartilage changes in experimental polyarthritis.
Koufany M; Moulin D; Bianchi A; Muresan M; Sebillaud S; Netter P; Weryha G; Jouzeau JY
Arthritis Res Ther; 2008; 10(1):R6. PubMed ID: 18199331
[TBL] [Abstract][Full Text] [Related]
7. Effects of a PPAR-gamma agonist, on growth factor and insulin stimulated endothelial cells.
Desouza CV; Gerety M; Hamel FG
Vascul Pharmacol; 2009; 51(2-3):162-8. PubMed ID: 19520186
[TBL] [Abstract][Full Text] [Related]
8. Rosiglitazone antagonizes vascular endothelial growth factor signaling and nuclear factor of activated T cells activation in cardiac valve endothelium.
Sander TL; Noll L; Klinkner DB; Weihrauch D; He BJ; Kaul S; Zangwill SD; Tweddell JS; Pritchard KA; Oldham KT
Endothelium; 2006; 13(3):181-90. PubMed ID: 16840174
[TBL] [Abstract][Full Text] [Related]
9. Peroxisome proliferator-activated receptor alpha and gamma ligands inhibit the growth of human ovarian cancer.
Shigeto T; Yokoyama Y; Xin B; Mizunuma H
Oncol Rep; 2007 Oct; 18(4):833-40. PubMed ID: 17786343
[TBL] [Abstract][Full Text] [Related]
10. PPARgamma agonists inhibit angiogenesis by suppressing PKCalpha- and CREB-mediated COX-2 expression in the human endothelium.
Scoditti E; Massaro M; Carluccio MA; Distante A; Storelli C; De Caterina R
Cardiovasc Res; 2010 May; 86(2):302-10. PubMed ID: 20032081
[TBL] [Abstract][Full Text] [Related]
11. Keratinocyte-derived vascular endothelial growth factor biosynthesis represents a pleiotropic side effect of peroxisome proliferator-activated receptor-gamma agonist troglitazone but not rosiglitazone and involves activation of p38 mitogen-activated protein kinase: implications for diabetes-impaired skin repair.
Schiefelbein D; Seitz O; Goren I; Dissmann JP; Schmidt H; Bachmann M; Sader R; Geisslinger G; Pfeilschifter J; Frank S
Mol Pharmacol; 2008 Oct; 74(4):952-63. PubMed ID: 18599600
[TBL] [Abstract][Full Text] [Related]
12. Pioglitazone ameliorates endothelial dysfunction and restores ischemia-induced angiogenesis in diabetic mice.
Huang PH; Sata M; Nishimatsu H; Sumi M; Hirata Y; Nagai R
Biomed Pharmacother; 2008 Jan; 62(1):46-52. PubMed ID: 17692499
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of corneal neovascularization by a peroxisome proliferator-activated receptor-gamma ligand.
Sarayba MA; Li L; Tungsiripat T; Liu NH; Sweet PM; Patel AJ; Osann KE; Chittiboyina A; Benson SC; Pershadsingh HA; Chuck RS
Exp Eye Res; 2005 Mar; 80(3):435-42. PubMed ID: 15721625
[TBL] [Abstract][Full Text] [Related]
14. Tetrathiomolybdate blocks bFGF- but not VEGF-induced incipient angiogenesis in vitro.
Mamou F; May KS; Schipper MJ; Gill N; Kariapper MS; Nair BM; Brewer G; Normolle D; Khan MK
Anticancer Res; 2006; 26(3A):1753-8. PubMed ID: 16827103
[TBL] [Abstract][Full Text] [Related]
15. BMP-9 signals via ALK1 and inhibits bFGF-induced endothelial cell proliferation and VEGF-stimulated angiogenesis.
Scharpfenecker M; van Dinther M; Liu Z; van Bezooijen RL; Zhao Q; Pukac L; Löwik CW; ten Dijke P
J Cell Sci; 2007 Mar; 120(Pt 6):964-72. PubMed ID: 17311849
[TBL] [Abstract][Full Text] [Related]
16. Nanoparticle-mediated delivery of pioglitazone enhances therapeutic neovascularization in a murine model of hindlimb ischemia.
Nagahama R; Matoba T; Nakano K; Kim-Mitsuyama S; Sunagawa K; Egashira K
Arterioscler Thromb Vasc Biol; 2012 Oct; 32(10):2427-34. PubMed ID: 22879581
[TBL] [Abstract][Full Text] [Related]
17. Vascular endothelial growth factors synthesized by human lung mast cells exert angiogenic effects.
Detoraki A; Staiano RI; Granata F; Giannattasio G; Prevete N; de Paulis A; Ribatti D; Genovese A; Triggiani M; Marone G
J Allergy Clin Immunol; 2009 May; 123(5):1142-9, 1149.e1-5. PubMed ID: 19275959
[TBL] [Abstract][Full Text] [Related]
18. Anti-angiogenic action of plasma hyaluronan binding protein in human umbilical vein endothelial cells.
Jeon JW; Song HS; Moon EJ; Park SY; Son MJ; Jung SY; Kim JT; Nam DH; Choi-Miura NH; Kim KW; Kim YJ
Int J Oncol; 2006 Jul; 29(1):209-15. PubMed ID: 16773202
[TBL] [Abstract][Full Text] [Related]
19. Angiogenic activity of bFGF and VEGF suppressed by proteolytic cleavage by neutrophil elastase.
Ai S; Cheng XW; Inoue A; Nakamura K; Okumura K; Iguchi A; Murohara T; Kuzuya M
Biochem Biophys Res Commun; 2007 Dec; 364(2):395-401. PubMed ID: 17950695
[TBL] [Abstract][Full Text] [Related]
20. Pioglitazone inhibits homocysteine-induced migration of vascular smooth muscle cells through a peroxisome proliferator-activated receptor gamma-independent mechanism.
Li L; Gao PJ; Xi R; Wu CF; Zhu DL; Yan J; Lu GP
Clin Exp Pharmacol Physiol; 2008 Dec; 35(12):1471-6. PubMed ID: 18759864
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
